The Effect of Estrogen Replacement Therapy on Visceral Fat, Serum Glucose, Lipid Profiles and Apelin Level in Ovariectomized Rats

참고문헌 (65)

1. Davidson LE, "Effects of exercise modality on insulin resistance and functional limitation in older adults:a randomized controlled trial", Arch Intern Med, 169, pp.122~131 (2009)
2. Mattu HS, "Role of adipokines in cardiovascular disease", J Endocrinol, 216, pp.T17~T36 (2013)
3. Paszkowski T, "Hormonalna terapia zastępcza", Przegl Menopauzalny, 2, pp.106~109 (2007)
4. Ferrara CM, "Differences in adipose tissue metabolism between postmenopausal and perimenopausal women", J Clin Endocrinol Metab, 87, pp.4166~4170 (2002)
5. Foster MT, "Metabolic alterations following visceral fat removal and expansion: Beyond anatomic location", Adipocyte, 1, pp.192~199 (2012)
6. Augoulea A, "Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels", Gynecol Endocrinol, 20, pp.227~235 (2005)
7. Blake J, "Menopause: evidence-based practice", Best Pract Res Clin Obstet Gynaecol, 20, pp.799~839 (2006)
8. Burger HG, "Hormonal changes in the menopause transition", Recent Prog Horm Res, 57, pp.257~275 (2002)
9. Utian WH, "Menopause-related definitions", Int Congr Ser, 1266, pp.133~138 (2004)
10. Mattsson C, "Estrogens and glucocorticoid hormones in adipose tissue metabolism", Curr Med Chem, 14, pp.2918~2924 (2007)
11. Misso ML, "Differential expression of factors involved in fat metabolism with age and the menopause transition", Maturitas, 51, pp.299~306 (2005)
12. Pedersen SB, "Estrogen controls lipolysis by upregulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution", J Clin Endocrinol Metab, 89, pp.1869~1878 (2004)
13. Ford ES, "Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey", JAMA, 287, pp.356~359 (2002)
14. Cekmez F, "Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance", Cytokine, 56, pp.387~391 (2011)
15. Corriveau P, "Resistance training prevents liver fat accumulation in ovariectomized rats", Maturitas, 59, pp.259~267 (2008)
16. Parvin Babaei, "The interaction effects of aerobic exercise training and vitamin D supplementation on plasma lipid profiles and insulin resistance in ovariectomized rats", Journal of Exercise Nutrition & Biochemistry, 19(3), pp.173~182 (2015), 한국운동영양학회
17. Edinger AL, "An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus", J Virol, 72, pp.7934~7940 (1998)
18. Tatemoto K, "Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor", Biochem Biophys Res Commun, 251, pp.471~476 (1998)
19. Hosoya M, "Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin", J Biol Chem, 275, pp.21061~21067 (2000)
20. Lee DK, "Characterization of apelin, the ligand for the APJ receptor", J Neurochem, 74, pp.34~41 (2000)
21. O’Dowd BF, "A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11", Gene, 136, pp.355~360 (1993)
22. Kawamata Y, "Molecular properties of apelin: tissue distribution and receptor binding", Biochim Biophys Acta, 1538, pp.162~171 (2001)
23. Devic E, "Expression of a new G protein-coupled receptor X-msr is associated with an endothelial lineage in Xenopus laevis", Mech Dev, 59, pp.129~140 (1996)
24. Esteve E, "Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin", Diabetes Care, 32(Suppl 2), pp.S362~S367 (2009)
25. Hus-Citharel A, "Effect of apelin on glomerular hemodynamic function in the rat kidney", Kidney Int, 74, pp.486~494 (2008)
26. Medhurst AD, "Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin", J Neurochem, 84, pp.1162~1172 (2003)
27. Tasci I, "Plasma apelin is lower in patients with elevated LDLcholesterol", Exp Clin Endocrinol Diabetes, 115, pp.428~432 (2007)
28. Trayhurn P, "Adipokines: inflammation and the pleiotropic role of white adipose tissue", Br J Nutr, 92, pp.347~355 (2004)
29. Wei L, "Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1adipocytes", Regul Pept, 132, pp.27~32 (2005)
30. Combs TP, "Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocytespecific secretory protein adiponectin", Diabetes, 52, pp.268~276 (2003)
31. Chapman NA, "The apelin receptor:physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR", Biochem Cell Biol, 92, pp.431~440 (2014)
32. Higuchi K, "Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice", Endocrinology, 148, pp.2690~2697 (2007)
33. Babaei P, "Effects of ovariectomy and estrogen replacement therapy on visceral adipose tissue and serum adiponectin levels in rats", Menopause Int, 16, pp.100~104 (2010)
34. Damirchi A, "Effects of aerobic exercise training on visceral fat and serum adiponectin concentration in ovariectomized rats", Climacteric, 13, pp.171~178 (2010)
35. Saengsirisuwan V, "Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement", Metabolism, 58, pp.38~47 (2009)
36. Zoth N, "Physical activity and estrogen treatment reduce visceral body fat and serum levels of leptin in an additive manner in a diet induced animal model of obesity", J Steroid Biochem Mol Biol, 122, pp.100~105 (2010)
37. Zoth N, "Metabolic effects of estrogen substitution in combination with targeted exercise training on the therapy of obesity in ovariectomized Wistar rats", J Steroid Biochem Mol Biol, 130, pp.64~72 (2012)
38. Azman A, "The effects of vitamin E on bodyweight and fat mass in intact and ovariectomized female rats", Med J Islam Acad Sci, 14, pp.125~138 (2001)
39. Wang JF, "Effects of Radix Puerariae flavones on liver lipid metabolism in ovariectomized rats", World J Gastroenterol, 10, pp.1967~1970 (2004)
40. Hoseini R, "Vitamin D increases PPARgamma expression and promotes beneficial effects of physical activity in metabolic syndrome", Nutrition, 36, pp.54~59 (2017)
41. Al-Wahaibi A, "Effects of ovariectomy on body weight and activity of 11-beta hydroxysteroid dehydrogenase type I In the liver and adipose tissue of rats", Sci J King Faisal Univ, 9, pp.149~162 (2008)
42. Choi SB, "Estrogen and exercise may enhance beta-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats", Endocrinology, 146, pp.4786~4794 (2005)
43. Meli R, "Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats", Endocrinology, 145, pp.3115~3121 (2004)
44. Mueller SO, "Immortalized testis cell lines from estrogen receptor (ER) alpha knock-out and wild-type mice expressing functional ERalpha or ERbeta", J Androl, 22, pp.652~664 (2001)
45. Choi KM, "The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors", Eur J Endocrinol, 150, pp.715~718 (2004)
46. Latour MG, "Metabolic effects of physical training in ovariectomized and hyperestrogenic rats", J Appl Physiol, 90, pp.235~241 (2001)
47. Ryan AS, "Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women", Diabetes Care, 25, pp.127~133 (2002)
48. D’Eon TM, "Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways", J Biol Chem, 280, pp.35983~35991 (2005)
49. Sites CK, "Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women", Metabolism, 50, pp.835~840 (2001)
50. Munoz J, "Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement", Obes Res, 10, pp.424~431 (2002)
51. Sumino H, "Effects of hormone replacement therapy on weight, abdominal fat distribution, and lipid levels in Japanese postmenopausal women", Int J Obes Relat Metab Disord, 27, pp.1044~1051 (2003)
52. Tchernof A, "Ovarian hormone status and abdominal visceral adipose tissue metabolism", J Clin Endocrinol Metab, 89, pp.3425~3430 (2004)
53. Wakatsuki A, "Estrogeninduced small low density lipoprotein particles may be atherogenic in postmenopausal women", J Am Coll Cardiol, 37, pp.425~430 (2001)
54. Heinonen MV, "Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding", Regul Pept, 130, pp.7~13 (2005)
55. Boucher J, "Apelin, a newly identified adipokine upregulated by insulin and obesity", Endocrinology, 146, pp.1764~1771 (2005)
56. Kleinz MJ, "Emerging roles of apelin in biology and medicine", Pharmacol Ther, 107, pp.198~211 (2005)
57. Li L, "Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects", Exp Clin Endocrinol Diabetes, 114, pp.544~548 (2006)
58. Rittig K, "Apelin serum levels are not associated with early atherosclerosis or fat distribution in young subjects with increased risk for type 2 diabetes", Exp Clin Endocrinol Diabetes, 119, pp.358~361 (2011)
59. Altinkaya SÖ, "Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome", Eur J Obstet Gynecol Reprod Biol, 176, pp.168~172 (2014)
60. Cebeci AN, "Perinephric adipose tissue thickness in relation to blood pressure, plasma apelin and C-reactive protein levels in obese adolescents", Minerva Endocrinol, 41, pp.166~174 (2016)
61. Cekmez F, "Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome", Eur Cytokine Netw, 22, pp.32~37 (2011)
62. Chang CY, "Lower serum apelin levels in women with polycystic ovary syndrome", Fertil Steril, 95, pp.2520~2523 (2011)
63. Choi YS, "Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-alpha levels in non-obese women with polycystic ovary syndrome", Steroids, 77, pp.1352~1358 (2012)
64. Tapan S, "Decreased plasma apelin levels in pubertal obese children", J Pediatr Endocrinol Metab, 23, pp.1039~1046 (2010)
65. Principe A, "The hepatic apelin system:a new therapeutic target for liver disease", Hepatology, 48, pp.1193~1201 (2008)

관련 논문AI추천